Hikim A P, Swerdloff R S
Division of Endocrinology, Harbor-UCLA Medical Center, Torrance 90509.
Endocrinology. 1994 Apr;134(4):1627-34. doi: 10.1210/endo.134.4.8137724.
This study examined the time course of recovery of spermatogenesis and its relationship to the temporal changes in circulating levels of gonadotropin and testosterone (T) and intratesticular T levels after cessation of treatment with a potent GnRH antagonist (GnRH-A). Adult male rats were given a daily sc injection of Nal-Glu-GnRH antagonist (1250 micrograms/kg BW) for 4 weeks and killed in groups of five 0, 1, 2, 3, 4, and 6 weeks after discontinuation of treatment. After cessation of treatment, plasma FSH levels returned to control values by 6 weeks, whereas LH levels returned to control values within 1 week. Both circulating as well as intratesticular levels of T returned to normal levels by 3 and 4 weeks, respectively. Interestingly, a rebound in both FSH and intratesticular T, but not in plasma T, beyond control levels occurred early in the recovery phase. The total volume of Leydig cells, which was only 15% of control values, increased 4.3-fold within 1 week and was not significantly different from control values (92% recovery) by 2 weeks posttreatment. Enumeration of earlier phases of germ cells as well as homogenization-resistant advanced (steps 17-19) spermatids revealed a progressive increase in germ cell numbers with time. Complete restoration of the numbers of preleptotene spermatocytes, pachytene spermatocytes, step 7 spermatids, and advanced spermatids occurred 1, 3, 4, and 6 weeks, respectively, after termination of GnRH-A treatment. There was also a complete reversal of GnRH-A-induced changes in testicular weight, tubule diameter, and volume of seminiferous tubules and their lumens by 6 weeks posttreatment, paralleling the recovery of spermatogenesis. These results suggest that 1) complete recovery of spermatogenesis and various other testicular parameters can be achieved in GnRH-A-treated rats after cessation of treatment; 2) the progression of various germ cells during the recovery period follows the normal time schedule of germ cell development; and 3) the recovery of spermatogenesis is preceded by supranormal levels of FSH and intratesticular T. These findings further emphasize the suitability of antagonistic analogs of GnRH for male fertility control.
本研究检测了用强效促性腺激素释放激素拮抗剂(GnRH-A)治疗停止后精子发生恢复的时间进程及其与促性腺激素和睾酮(T)循环水平以及睾丸内T水平随时间变化的关系。成年雄性大鼠每天皮下注射那法瑞林-Glu-GnRH拮抗剂(1250微克/千克体重),持续4周,并在停药后0、1、2、3、4和6周,每组五只处死。停药后,血浆促卵泡激素(FSH)水平在6周时恢复到对照值,而促黄体生成素(LH)水平在1周内恢复到对照值。循环以及睾丸内的T水平分别在3周和4周时恢复到正常水平。有趣的是,在恢复阶段早期,FSH和睾丸内T均出现超过对照水平的反弹,但血浆T未出现反弹。睾丸间质细胞总体积仅为对照值的15%,在1周内增加了4.3倍,在治疗后2周时与对照值无显著差异(恢复92%)。对生殖细胞早期阶段以及抗匀浆的晚期(第17-19步)精子细胞进行计数显示,生殖细胞数量随时间逐渐增加。在GnRH-A治疗终止后,细线前期精母细胞、粗线期精母细胞、第7步精子细胞和晚期精子细胞数量分别在1、3、4和6周时完全恢复。治疗后6周时,GnRH-A诱导的睾丸重量、小管直径、生精小管及其管腔体积的变化也完全逆转,这与精子发生的恢复平行。这些结果表明:1)在停止使用GnRH-A治疗后,经GnRH-A处理的大鼠可实现精子发生以及其他各种睾丸参数的完全恢复;2)恢复期间各种生殖细胞的发育进程遵循生殖细胞正常发育的时间进程;3)精子发生的恢复之前FSH和睾丸内T水平高于正常。这些发现进一步强调了GnRH拮抗类似物在男性生育控制方面的适用性。